This phase typically delivers the most dramatic before-and-after comparison when users review their starting point versus their current state
However, patient preference often favors semaglutide because of its superior weight loss and glycemic control outcomes, which can enhance motivation to continue treatment. Getting approved for Trulicity vs

Semaglutide Medication class: Semaglutide is a GLP-1 receptor agonist Tirzepatide acts on both GLP-1 and GIP receptors Use: Both are injectable prescription medications used alongside diet and exercise to support blood sugar regulation and weight management in adults Dosing: Both medications are typically administered as a once-weekly injection, based on individual treatment plans Effect profile: Both work by influencing appetite regulation and glucose metabolism Individual response and tolerance may vary Side effects: Common side effects may include nausea, vomiting, diarrhea, constipation, or abdominal discomfort Side effects and tolerability differ between individuals Treatment selection: Choice of medication is based on medical history, clinical evaluation, and provider recommendation Formulation: At NP ON DEMAND, these medications may be provided as compounded formulations, which may include bacteriostatic water (BAC), vitamin B12, or glycine, depending on individual treatment plans Who Should Not Use GLP-1 Medications

WEGOVY tablet or matching placebo was escalated to a 25 mg tablet once daily during a 12-week period followed by 52-week maintenance period